0911 Trax
BioCentury & Getty Images

Management Tracks

New CEO Hirsch to guide C4 onto NASDAQ; plus Biller adds CFO title at Agios and updates from Sherlock, Lumen and more

Sep 12, 2020 | 2:15 AM GMT

It’s been a busy week for C4 Therapeutics Inc., which hired a new CEO and filed to go public. Andrew Hirsch is joining the protein degradation company from Agios Pharmaceuticals Inc. (NASDAQ:AGIO), where he has been CFO and head

Read the full 672 word article

How to gain access

Continue reading with a
two-week free trial.